Insider Transactions in Q3 2025 at Ardelyx, Inc. (ARDX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2025
|
Laura A Williams Chief Patient Officer |
SELL
Open market or private sale
|
Direct |
80,000
-9.39%
|
$480,000
$6.12 P/Share
|
|
Aug 26
2025
|
Laura A Williams Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+10.07%
|
$0
$0.99 P/Share
|
|
Aug 21
2025
|
Mike Kelliher Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,417
-1.92%
|
$27,085
$5.93 P/Share
|
|
Aug 21
2025
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,037
-1.69%
|
$35,185
$5.93 P/Share
|
|
Aug 21
2025
|
Laura A Williams Chief Patient Officer |
SELL
Open market or private sale
|
Direct |
6,261
-1.56%
|
$31,305
$5.93 P/Share
|
|
Aug 21
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
45,687
-2.95%
|
$228,435
$5.93 P/Share
|
|
Aug 21
2025
|
Eric Duane Foster Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,308
-4.83%
|
$76,540
$5.93 P/Share
|
|
Aug 21
2025
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
5,841
-1.87%
|
$29,205
$5.93 P/Share
|